Study finds higher steroid doses linked to better recovery in sudden hearing loss

Patients receiving higher average daily doses were almost 10 times more likely to achieve favourable outcomes than those receiving lower doses. Image: luchschenF/stock.adobe.com. Patients with sudden sensorineural hearing loss (SSNHL) may achieve better short-term hearing recovery when treated with higher doses of systemic steroids, according to a new study....

Continue reading at Hearing Practitioner Australia →

This study suggests that higher average daily steroid doses may significantly improve short-term hearing recovery in SSNHL; however, without knowing study design details (RCT vs. retrospective, confounders, dose thresholds, and safety data), clinicians should treat this as hypothesis-strengthening rather than grounds for immediate protocol change — pending review of the full paper.

Optimising steroid dosing for sudden sensorineural hearing loss is one of the most clinically debated areas in audiology and ENT, and a near 10-fold odds ratio for recovery — if robust — could reshape prescribing guidelines.

1. 01Patients with sudden sensorineural hearing loss (SSNHL) on higher daily steroid doses were ~10× more likely to achieve favourable short-term hearing recovery.
2. 02The study reinforces steroids as the primary medical intervention for SSNHL, with dose magnitude appearing critical.
3. 03Dose thresholds, steroid type, and route of administration details are not specified in the available summary.
4. 04Short-term outcomes only — longer-term hearing recovery data and side-effect profiles were not reported in this summary.
5. 05Findings support re-examining current dosing protocols but require full study appraisal before clinical adoption.

Publication type

research_article

Evidence level

4

Population

Patients with sudden sensorineural hearing loss (SSNHL)

Intervention

Higher average daily steroid doses

Comparator

Lower average daily steroid doses